Life Spectrum of Asthma

The Life Spectrum of Asthma: Online

The incidence and prevalence of asthma has increased considerably in recent years. Asthma is not a single disease, and its expression, remission, progression, and severity can vary based on age and gender. Therefore, it is crucial for allergist/immunologists, as specialists in the diagnosis and management of asthma, to understand how to select the most appropriate patients for the use of immune response modifiers and how to assess and manage the risk-benefit ratio of treatment. The Life Spectrum of Asthma: Online provides learners with a comprehensive understanding of how to do exactly that, by incorporating cutting-edge science and discussion of newly and soon-to-be approved biologic therapies. 

The program consists of four modules that were purposefully designed to cover the diagnosis, assessment, and treatment over the entire life spectrum of asthma, including:

  1. Asthma Inception and Progression
  2. Reducing and/or Eliminating Asthma Exacerbations
  3. Preventing and Treating Severe Asthma
  4. Asthma and COPD Overlap Syndrome (ACOS)

The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™ for the completion of each module or 8.00 AMA PRA Category 1 Credits™ for the completion of all four. 

At the bottom of this page, you may select to purchase the full course or individual modules. After making your selection, click the red ENROLL button. Begin your courses by clicking the module names at the bottom of this page.

Special Pricing is Available for the Following Groups:
-Allied Health and Fellows-in-Training: Contact for $100 registration
-Attendees of the Live Course (July 2016): Contact for a 50% discount

The Life Spectrum of Asthma: Online is funded through an educational grant from GlaxoSmithKline.

Target Audience

  • Allergist/Immunologists
  • Fellows-in-Training
  • Allied Health providers 

Learning Objectives

Upon completion of this activity, participants should be able to: 

Module 1: Asthma Inception and Progression
-Describe the mechanistic characteristics of asthma in young children
-Identify appropriate treatment methodologies for young children with asthma

Module 2: Reducing and/or Eliminating Asthma Exacerbations
-Describe the biological characteristics of asthma exacerbations
-Outline the appropriate use of biologic therapies to treat asthma exacerbations

Module 3: Preventing and Treating Severe Asthma
-Define the mechanistic and clinical characteristics of severe asthma
-Differentiate difficult to treat from severe asthma

Module 4: Asthma and COPD Overlap Syndrome (ACOS)
-Compare and contrast the biological and environmental characteristics of asthma and COPD
-Define appropriate treatment strategies of ACOS

Course opens: 
Course expires: 
Member cost:

Speakers and disclosures will be listed with each talk.

Planning Committee Disclosures
Thomas B. Casale, MD FAAAAI
University of South Florida
Relevant relationships: Sanofi-Regeneron, Teva, Novartis, Genentech, Boehringer Ingelheim, AstraZeneca (advisory board); Allerquest, Circassia, Capnia (consultant); Parexel (honorarium)

Robert F. Lemanske, Jr., MD FAAAAI
University of Wisconsin 
Relevant relationships: Pharmaxis (research funding) 

CME Committee Reviewers
Kim E. Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant relationships: None

Kevin W. Parks, MD FAAAAI
AAC/CRI of Southern Oregon, Medford, OR 
Relevant relationships: None

Activity Title
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.
Please login or register to take this course.


Member cost:
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is not supported.